Vepalabs, a veterinary point of care diagnostics distribution company and M3DICINE, a medical device platform company, have signed a distribution agreement to sell the world’s first veterinary digital AI enabled stethoscope.
The agreement covers sales in Australia and New Zealand and marks the first time a digital AI-enabled stethoscope has been focused on improving the experience and efficiency of acquiring, storing, sharing and diagnosing animal vital sign data.
Animals often have a ‘flight or fight’ reaction to seeing a traditional stethoscope, resulting too often in the vet being scratched or bitten. One of the many benefits of Stethee Vet is that the device can be used by the pet owner with the vet listening and capturing the pet’s vital signs wirelessly or on their mobile device.
The animal’s vital signs are instantly uploaded to the cloud where intelligent AI software analyses and compares millions of related vital signs to help the vet make informed diagnostic decisions.
“We’re delighted to be first to market with such an innovative veterinary platform in Australasia,” Vepalabs product manager Jack Mainprize said.
“Stethee Vet’s groundbreaking design and artificially intelligent software heralds in a new era of innovation across the veterinary market, helping to improve diagnostics, screening and remote care for veterinary health professionals and animal owners.”
Founder and CEO of M3DICINE Nayyar Hussain said: “As a Brisbane company we’re looking forward to building our partnership with Vepalabs to help enable the animal health market for AI and digital diagnostic platforms.
“Stethee Vet not only dramatically improves the way vets can hear, record, analyse, compare and share heart and respiratory sounds, but we discovered in early trials, that it also improves the visit experience for pets and pet owners.”